about
Synthesis of an experimental glycolipoprotein vaccine against Lyme diseaseA newly discovered cholesteryl galactoside from Borrelia burgdorferiAdditional conjugation methods and immunogenicity of Bacillus anthracis poly-gamma-D-glutamic acid-protein conjugatesBacillus anthracis cell wall peptidoglycan but not lethal or edema toxins produces changes consistent with disseminated intravascular coagulation in a rat model.A bicomponent Plasmodium falciparum investigational vaccine composed of protein-peptide conjugates.Oligosaccharide conjugates of Bordetella pertussis and bronchiseptica induce bactericidal antibodies, an addition to pertussis vaccine.Immunochemical studies of Shigella flexneri 2a and 6, and Shigella dysenteriae type 1 O-specific polysaccharide-core fragments and their protein conjugates as vaccine candidates.The structure of the Escherichia coli O148 lipopolysaccharide core region and its linkage to the O-specific polysaccharide.Pre- and postexposure protection against virulent anthrax infection in mice by humanized monoclonal antibodies to Bacillus anthracis capsulePertussis vaccine: a critique.Synthesis and antigenicity of BBGL-2 glycolipids of Borrelia burgdorferi, the causative agent of Lyme disease.Poly(gamma-D-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: a potential addition to the anthrax vaccine.Long-lasting and transmission-blocking activity of antibodies to Plasmodium falciparum elicited in mice by protein conjugates of Pfs25.Bacillus anthracis Capsular Conjugates Elicit Chimpanzee Polyclonal Antibodies That Protect Mice from Pulmonary Anthrax.Identification of the methyl phosphate substituent at the non-reducing terminal mannose residue of the O-specific polysaccharides of Klebsiella pneumoniae O3, Hafnia alvei PCM 1223 and Escherichia coli O9/O9a LPSO-Acetylation in the O-specific polysaccharide isolated from Shigella flexneri serotype 2aEffect of the nonreducing end of Shigella dysenteriae type 1 O-specific oligosaccharides on their immunogenicity as conjugates in mice.The study of the core part and non-repeating elements of the O-antigen of Brucella lipopolysaccharideThe capsular polysaccharide and lipopolysaccharide structures of two carbapenem resistant Klebsiella pneumoniae outbreak isolates.Saccharides cross-reactive with Bacillus anthracis spore glycoprotein as an anthrax vaccine componentSaccharide/protein conjugate vaccines for Bordetella species: preparation of saccharide, development of new conjugation procedures, and physico-chemical and immunological characterization of the conjugates.The structure of the carbohydrate backbone of the LPS from Shewanella spp. MR-4.The elucidation of the structure of the core part of the LPS from Plesiomonas shigelloides serotype O17 expressing O-polysaccharide chain identical to the Shigella sonnei O-chainReinvestigation of the structure of Brucella O-antigens.Synthetic oligosaccharides as tools to demonstrate cross-reactivity between polysaccharide antigens.Synthesis, characterization, and immunogenicity in mice of Shigella sonnei O-specific oligosaccharide-core-protein conjugatesChemical structure, conjugation, and cross-reactivity of Bacillus pumilus Sh18 cell wall polysaccharide.Toward a new vaccine for pertussisVaccination with Shigella flexneri 2a conjugate induces type 2a and cross-reactive type 6 antibodies in humans but not in mice.A new method for conjugation of carbohydrates to proteins using an aminooxy-thiol heterobifunctional linker.Synthesis of octa- and dodecamers of D-ribitol-1-phosphate and their protein conjugates.Immunogenic and adjuvant properties of Haemophilus ducreyi lipooligosaccharides.Conjugation of LPS-derived oligosaccharides to proteins using oxime chemistry.A T-cell receptor escape channel allows broad T-cell response to CD1b and membrane phospholipidsComplete structures of Bordetella bronchiseptica and Bordetella parapertussis lipopolysaccharides
P50
Q22252326-43AA79FA-4CD2-4C59-AD8D-57A7DC004373Q24670017-93A0D1FB-A21E-421A-AF04-BB7B976F0A14Q33251442-66A98977-0946-459C-885B-99BED7D17091Q33408203-FE7589E2-E9C7-4B27-97BA-5515DAB0EEF8Q33524699-E90A9CF4-5DED-4481-B0C2-2C4116AA6FA4Q33835015-E75324FE-5D93-4E71-B17A-8C09DDE25110Q33987735-594D2236-CA5E-4063-93D8-C3223540914EQ34424977-E35D2615-C04F-424D-BA17-EB4CFE23181CQ34490786-C8A9B857-D409-4567-98AD-BA4DEB63A7F8Q34657980-09AD5F99-C0D7-4E67-B27E-089097AB19EEQ35099146-A054964B-6BD5-47AF-A189-C00206FF480AQ35171265-8CFB171E-AA58-4EFA-8A2E-31B22BFCD6D8Q35575993-52E9F1C6-D9FE-4621-8370-7DEB86599AAEQ35652068-2671CA98-1A1E-40ED-95A4-44C3B0C3BC3EQ35663402-8642F29F-CC70-49AC-B020-A4BA3EBC4653Q35828313-02CAE317-9149-4D4C-88C7-0BD508227891Q35955978-06AA9F3A-E271-4840-9474-C997C97FFAA3Q36518188-50AA3BB5-A9CE-4ACA-B3E4-A5B479E1F2B4Q36674044-02C4BE85-A1CB-4811-BB77-F030C2F5EACAQ36735285-DE5B2913-68DB-462E-9824-87FC0E194F19Q36842967-853B2B41-3951-4BEA-A555-4F7E4460423AQ36961155-2BF4A9F5-BC2C-4A0C-B644-5E0B841DF281Q36993963-5889BC1C-A51B-4CF4-826B-229DC6EC9609Q37097772-3369F626-22E8-43FD-BC7E-1DDD5E850363Q37102385-9C8E5EE8-505B-47F2-88E1-74B463008013Q37194696-1F21943D-1E49-46A6-9AA3-D261D27007EDQ37573805-3985AC15-16FF-463E-82F1-C24059FF2527Q37628007-25051D57-A867-4B9A-AA28-55F37A0FA78EQ40098097-40DB6E32-DE32-42D7-8AC3-D83C971BA554Q46645826-35DF9E7D-DAAD-4DA6-9DE7-C6EA8A547E3AQ46927723-92BA67CA-2D30-4B2B-B81E-972F8ABD0E82Q47932312-3C3C4D60-D1E0-4D85-BDC2-8AEC5030666FQ51864103-43A8A67E-E331-41A9-AE26-603785310A66Q60920987-2E8430C2-D800-4C26-9A3E-9020A04DCAACQ83189235-BE51D8C1-D146-4C6D-81C1-0847D6B23AB1
P50
name
Joanna Kubler-Kielb
@en
type
label
Joanna Kubler-Kielb
@en
prefLabel
Joanna Kubler-Kielb
@en
P21
P214
58146936840613782958